NAIC fast-tracks decision on Apollo CLO variants
The outcome will determine whether insurers can treat private credit securitizations as bonds, and how deep the buy-and-hold bid for the reset wave runs.
Creditflux reports that the National Association of Insurance Commissioners is fast-tracking a decision on whether securitized products such as Apollo's AMAPS and APADS can be sold to insurers as bonds, and the report — citing DLA Piper partner Robert Fettman — puts the insurance regulator at the center of private credit's newest funding frontier.
The question is whether the market's largest pool of long-dated capital, insurance reserves, can be tapped by the newest wave of CLO structures, and the CLO market has spent the past month refinancing and resetting seasoned transactions so that variants packaging private credit collateral are the next step in that arc. As PCD reported, Sona priced Europe's first hybrid BSL-private credit CLO last week, fusing syndicated and private credit collateral in one liability stack through Goldman Sachs; Apollo's AMAPS and APADS appear to be an American answer to the same instinct, a security built to fit the statutory accounting definition of a bond.
The fast-track nature of the NAIC review suggests urgency, because regulators rarely move quickly on securitization questions and an accelerated timetable implies the structures are either being marketed to insurers now or are close to it. Fettman does not say in Creditflux's report which way the NAIC is leaning, but a fast track exists only because a regulator wants to rule before the product becomes a habit.
We have argued before that CLO resets are private credit's true liquidity valve: a reset extends a vehicle's life and reprices liabilities but does not change who can buy the paper, whereas a CLO variant that insurers can hold as bonds would open a new channel entirely. Managers that treat CLO structuring as funding will have the cheapest cost of capital, and the NAIC's decision will determine whether that funding can flow through insurance reserves or remains confined to institutional funds and banks.
The classification question is binary and therefore high-stakes. If AMAPS and APADS are treated as bonds, insurers can hold them at bond-like statutory capital charges, making them cheap to carry for a buy-and-hold investor; any other treatment raises the capital charge sharply and diminishes the product's appeal. That binary outcome is why the fast-track decision matters beyond Apollo, and why every private credit manager with a securitization team is likely watching — even those not currently marketing into insurance channels.
The acronyms themselves are opaque, which is rarely a positive in a regulatory review. Creditflux's report gives no expansion of AMAPS or APADS, and that narrowness argues for caution. The CLO market's strength has been transparency and a multi-decade track record; a variant that seeks insurance capital without disclosing its collateral mechanics would be a lesser instrument.
The reset wave has shown that managers can lower funding costs and extend maturities by refinancing their own vehicles, and the next frontier is expanding the buyer base for those liabilities. Insurers are the logical next buyer, since they carry long-dated liabilities and a structural need for yield, but they are also regulated and the NAIC is the gatekeeper. A decision that treats Apollo's variants as bonds would open the door for other managers to follow; a decision that gates them leaves the funding valve exactly where it is.
Creditflux's report does not say when the NAIC will rule, though fast-track in regulatory terms usually means weeks, not years. When the ruling lands, the next generation of private credit securitization will either have a new buyer pool in insurance reserves or a known wall to route around. Apollo has forced the conversation; every other manager with a CLO team is now watching the same regulatory clock.